Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, May 2008, p. 1862-1864, Vol. 52, No. 5
0066-4804/08/$08.00+0 doi:10.1128/AAC.01208-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Division of Infectious Diseases, Department of Medicine, University of California, San Diego, La Jolla, California
Received 12 September 2007/ Returned for modification 1 November 2007/ Accepted 29 February 2008
Rapid emergence of resistance to monotherapy with virus-specific inhibitors necessitates combination therapy. ACH-806 is a hepatitis C virus NS4A inhibitor with a novel mechanism of action and resistance pathway. This compound was synergistic with NS3 protease inhibitors and NS5B nucleoside and nonnucleoside polymerase inhibitors.
Published ahead of print on 10 March 2008.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»